A3MZ07 AF NFT

Ubiquinone biosynthesis O-methyltransferase

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeihtqy54o7ytter35jc24wqgutsxyegmgvbk5b3ylqbq7t6x3ux3ky/metadata.json
IPFS of structure file: 
bafybeifwxzznwtkprkocmrbv5dnep4dozdyajluj5hmry5yj7bskuvf7xy/AF-A3MZ07-F1-model_v2.pdb
First NFT owner address (eip-55): 
0x1E0eee7983167EB59659813378f416516c8fA57b
First NFT owner address (bech32): 
genesis1rc8wu7vrzeltt9jesyeh3aqk29kglftma42c4s
Current NFT ID #486560 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1_w

NFT id:
486560
Accession (UniProt):
A3MZ07
Name::
Ubiquinone biosynthesis O-methyltransferase
Experimental Method:
Predicted structure
Sequence source:
Actinobacillus pleuropneumoniae serotype 5b (strain L20)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT A3MZ07 research and analysis (ICN3D with VR)

FASTA sequences

>sp|A3MZ07|UBIG_ACTP2 Ubiquinone biosynthesis O-methyltransferase OS=Actinobacillus pleuropneumoniae serotype 5b (strain L20) OX=416269 GN=ubiG PE=3 SV=1 MNNIDQTELDKFEKMAATWWDPNGSFKPIHLLNPLRLDYIQQKANGLFGKKVLDVGCGGGILSEAMARAGATVTGIDMTTEPLEVARKHAEENGLSIDYRQTTIEDFVQNQTACHAEKFDVITCMEMLEHVPDPLSIIQSCKALLKPDGVLFFSTINRTLKAYMLVIIGAEYVLKMLPKGTHEFEKFIKPAELLNWCDMADLRCQEMKGYHFNPVTEKFWLNNDVSCNYIAMLK